Stay up to date with our latest news and events.
Partner with Proteos, a proud US-based service company, to advance your discovery research program. Contact us today to start the conversation. Wishing you a safe and enjoyable holiday!
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. Here we will focus on the use of affinity tags in recombinant antigen production.
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. These variables include construct design, affinity tags, expression system, purification scheme, formulation, and characterization. Here we will focus on selecting an appropriate expression system for recombinant antigen production.
In celebration of Arbor Day, let us all consider how we can contribute to conservation of our environment, for present and for future generations.
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. These variables include expression system, purification techniques, protein tags, formulation, and assessment.
Proteos is an industry leader in the production of high-quality recombinant antibodies for drug discovery research. Here we will focus on the benefits of producing mAbs recombinantly in mammalian cells.
Proteos is an industry leader in the production of high-quality recombinant antibodies for drug discovery research. There are multiple methods for production of monoclonal antibodies, including hybridoma cell lines and recombinant protein technology. The following information will discuss some of the limitations of hybridoma production.
Thank you to our valued customers for your business and support in 2020. We wish you a joyous holiday season and look forward to working with you in 2021.
Proteos would like to wish you, your family, and your friends a very Happy Thanksgiving!
More than 6 million people worldwide are living with Parkinson’s Disease. Proteos has proudly partnered with The Michael J. Fox Foundation to provide high-quality protein reagents in support of Parkinson’s disease research.
